[CLDX] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
07-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- 55.85%
YoY- 72.53%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 715 1,425 1,764 941 2,763 4,068 3,456 -65.12%
PBT -11,779 -17,239 -9,402 -7,243 -16,407 -118,897 -22,923 -35.92%
Tax -2,990 5,234 -8,746 -14,912 -15,798 -765 -19,082 -71.03%
NP -11,779 -17,239 -9,402 -7,243 -16,407 -118,132 -3,841 111.51%
Tax Rate - - - - - - - -
Total Cost 12,494 18,664 11,166 8,184 19,170 122,200 7,297 43.26%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin -1,647.41 -1,209.75 -532.99 -769.71 -593.81 -2,903.93 -111.14 506.40%
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -0.84 -1.40 -0.81 -0.66 -1.67 -12.61 -0.42 58.94%
EPS Diluted -0.84 -1.40 -0.81 -0.66 -1.67 -12.61 -0.41 61.52%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.